The Top 10 Phase III Failures of 2010

The Top 10 Phase III Failures of 2010

Submitted by admin on October 22, 2010 - 11:36am
Source: 
Fierce Biotech
News Tags: 
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Headline: 
The Top 10 Phase III Failures of 2010

Do Not Allow Advertisers to Use My Personal information